¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°èÇмú´ëȸ : 2021-10-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°èÇмú´ëȸ : 2021-10-29
±³À°ÀÏÀÚ : 2021-10-29
±³À°Àå¼Ò : ¼­¿ï ¹Ð·¹´Ï¾öÈúÆ°È£ÅÚ, ÁöÇÏ1Ãþ ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : 2021 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç¥ÀûÄ¡·á¿¬±¸È¸  
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540  
À̸ÞÀÏ : kalc@lungca.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000¿ø/ ºñȸ¿ø 60,000¿ø ÇöÀåµî·Ï ȸ¿ø: 60,000¿ø/ ºñȸ¿ø 70,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 11:00~11:30 ¼ö¿ù¼ºÀÌ È®º¸µÈ ¿¬±¸¸¦ À§ÇÑ Á¦¾ð  ¹ÚÇåÁÖ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 11:30~12:00 3D Cancer Genome: A new method to predict the functional consequences of structural variation  Á¤Àΰæ(KAIST) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 12:00~12:30 TME of early lung adenocarcinoma from non-smokers and its usefulness as a therapeutic target  ÀåÀ±¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 12:30~13:30 Synergy of IO/IO combination in NSCLC 1L and Mesothelioma 1L   ¹Ú¼øÈ¿(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 13:30~14:00 Isolation and characterization of extracellular vesicles  ¹ÚÀ缺(Æ÷Ç×°ø´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 14:00~14:30 Next Generation Proteomics of Extracelullar Vesicles in Lung Adenocarcinoma.  ¹éÁ¦Çö((Àç)¾¾Á¨ÀÇ·áÀç´Ü) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 14:30~15:00 Exosome-based BALiquid EGFR genotyping in real world practice  ±èÈñÁ¤(°Ç±¹ÀÇ´ë) 
È޽Ġ10-29  15:00~15:30 Coffee break  () 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 15:30~16:00 Current status and updates of lung cancer diagnosis in Korea  ±è·ç½Ã¾Æ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 16:00~16:30 Evolution of lung cancer and its clinical implication: A pathologist¡¯s view  ÀÌ¿ÁÁØ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 16:30~17:00 Digital pathology: Current status and future direction  ÀåÇýÀ±(µö¹ÙÀÌ¿À) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 17:00~17:15 Identication of the role of regulatory T cell as predictive biomarker for ecacy of immune checkpoint blockade in lung cancer  ÀÌÁ¤Àº(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 10-29 ÁöÇÏ1Ãþ ±×·£µåº¼·ë 17:15~17:30 Afatinib mediates autophagic degradation of ORAI1, STIM1, and SERCA2, which inhibits proliferation of non-small cell lung cancer cells  ¾ç¼¼ÈÆ(¿ø±¤ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°èÇмú´ëȸ : 2021-10-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇѾȰúÇÐȸ Á¦126ȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾Æ.ÅÂÆò¾ç ¾È¿µ»óÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2021-10-29
´ÙÀ½±Û (¿Â¶óÀÎ) 2021³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ (2ÀÏÂ÷) : 2021-10-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21045 ¼­¿ï 2024³â Á¦23ȸ ´ëÇÑôÃ߽űâ¼úÇÐȸ Ãá°è Á¤±âÇмú´ëȸ : 2024-06-29 0 6 2024-06-18
21044 ¼­¿ï (¿Â¶óÀÎ)2024³â »ó¹Ý±â ÀÇ·áºÐÀï ¿¹¹æ ¿¬¼ö±³À° : 2024-06-29 0 9 2024-06-18
21043 ºÎ»ê 2024³â ºÎ¿ï°æ ½½°üÀý ¿¬±¸È¸ ÇÏ°è¿öÅ©¼¥ : 2024-06-29 0 9 2024-06-18
21042 ¼­¿ï ´ëÇѳú½Å°æÀçÈ°ÇÐȸ Á¦10Â÷ °æÁ÷Àü¹®±³À°°úÁ¤ : 2024-06-29 0 13 2024-06-18
21041 ¼­¿ï Çѱ¹¿©¼ºÁ¤½ÅÀÇÇÐȸ ³­¹Î/ÀÌÁֹΠÁ¤½Å°Ç°­ : 2024-06-29 0 7 2024-06-18
21040 °æ±â Á¦12ȸ ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø ½Å°æ¿Ü°ú ¿¬¼ö°­Á : 2024-06-29 0 3 2024-06-18
21039 ºÎ»ê 2024³â Á¦2ȸ ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Transitional Urology Symposium : 2024-06-29 0 11 2024-06-18
21038 ¼­¿ï 2024³â ´ëÇѳëÀνŰæÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-29 0 14 2024-06-18
21037 ¼­¿ï Á¦6ȸ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-06-29 0 15 2024-06-18
21036 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-29 0 10 2024-06-18
21035 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 5 2024-06-18
21034 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 2ÀÏÂ÷ : 2024-06-28 0 6 2024-06-18
21033 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦298Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-28 0 20 2024-06-18
21032 ¼­¿ï 2024 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-06-28 0 8 2024-06-18
21031 ¼­¿ï (2ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-28 0 7 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷